Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,34009,1593,0.66 [0.58-0.74],2.674216555110729e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,42051,2384,0.64 [0.58-0.71],3.505375546113296e-17
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,48206,1123,0.52 [0.45-0.60],2.7312983544628453e-18
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,48170,1087,0.50 [0.43-0.58],8.361029735919972e-20
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,41700,2033,0.62 [0.56-0.69],2.544001831132157e-17
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,41545,1878,0.61 [0.55-0.69],3.211081029291175e-17
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,Any mental disorder,44014,1328,0.74 [0.65-0.84],6.569101765343894e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Neurological diseases,44486,2999,0.75 [0.68-0.82],2.417343872725578e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,36827,6634,0.69 [0.64-0.74],1.0409073909268277e-23
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Hypertension, essential",38778,4578,0.64 [0.59-0.70],1.7125885582311658e-26
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Hypertension,38847,4647,0.64 [0.59-0.70],1.1583908389376822e-26
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",47592,2425,0.71 [0.64-0.79],6.313861275086737e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Angina pectoris,46622,1455,0.71 [0.63-0.81],1.2658253239525928e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,50398,969,0.70 [0.60-0.81],4.460945208005753e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",45768,601,0.64 [0.52-0.77],4.225809897519301e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,47060,1929,0.67 [0.60-0.75],1.909223783983823e-12
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,49642,161,0.48 [0.34-0.68],3.624626677618947e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,49743,262,0.50 [0.38-0.65],6.562288854690323e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,41487,4163,0.72 [0.67-0.78],9.646789537451211e-17
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,50135,508,0.65 [0.53-0.80],4.6735686913465445e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,50124,497,0.65 [0.53-0.80],5.131104132017919e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,46479,2045,0.68 [0.61-0.75],6.409954752070234e-13
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Early onset COPD,49642,356,0.55 [0.43-0.70],1.4912649187155165e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",49695,409,0.56 [0.44-0.70],3.796894281538039e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",49695,409,0.56 [0.44-0.70],3.796894281538039e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",48521,1689,0.74 [0.66-0.83],1.886181683297105e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Asthma,37145,1689,0.66 [0.59-0.74],9.305103004231233e-12
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",36600,1689,0.66 [0.59-0.74],7.513197859619007e-12
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",37120,1664,0.66 [0.58-0.74],8.157878472385006e-12
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,51282,182,0.34 [0.25-0.47],2.2958431733431096e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Interstitial lung disease,49035,140,0.27 [0.19-0.39],6.314799921153624e-13
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",51442,140,0.29 [0.20-0.41],1.1914013231003336e-12
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,49021,126,0.28 [0.19-0.41],3.3454050825954566e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,35372,11765,0.84 [0.79-0.88],1.1813003627188016e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",43374,4374,0.86 [0.79-0.92],6.752354173411777e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",51766,276,0.51 [0.39-0.66],7.255404337483127e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Ulcerative colitis,48811,276,0.50 [0.38-0.65],5.276687006289621e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",48783,248,0.50 [0.37-0.66],1.6408238096601736e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,50906,258,0.51 [0.38-0.68],4.305695728186451e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,41274,8622,0.86 [0.81-0.91],1.78760654799427e-07
